Acetylsalicylic acid: Clinical Trials

183 trials of Acetylsalicylic acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

93 completed, 41 unknown, 14 recruiting, 12 terminated. 68 Phase 3, 59 Phase 2, 27 Phase 4, 21 Not applicable, 12 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 368Completed 26, Unknown 18, Recruiting 7, Not yet recruiting 5, Terminated 5, Withdrawn 4, Active not recruiting 3
Phase 259Completed 31, Unknown 15, Active not recruiting 5, Not yet recruiting 3, Terminated 3, Recruiting 1, Suspended 1
Phase 427Completed 14, Unknown 8, Recruiting 3, Terminated 2
Not applicable21Completed 11, Unknown 5, Active not recruiting 2, Recruiting 2, Withdrawn 1
Phase 112Completed 12
Early Phase 19Completed 3, Unknown 3, Terminated 2, Recruiting 1

Follow Acetylsalicylic acid: new trials by email Literature Review of Acetylsalicylic acid trials Research Report on Acetylsalicylic acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
IVIG, Aspirin, Firsekibart - Kawasaki Disease
Phase 2 / Phase 3Not yet recruitingChildren's Hospital of Fudan University902026-11-012026-10-22
Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial
Low-dose aspirin, Placebo Comparator - Liver Cirrhosis
Phase 3Not yet recruitingCurtin University8902026-06-012026-04-14
Aspirin Dosing in Pregnancy
Aspirin - Preeclampsia Possible
Early Phase 1RecruitingNYU Langone Health302026-04-272026-05-18
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
Tirofiban, Acetylsalicylic acid - Acute Ischemic Stroke
Phase 4CompletedFundación Pública Andaluza para la gestión de la Investigación en Sevilla2402026-03-202026-04-03
Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI
Aspirin, P2Y12 inhibitor - Coronary Artery Disease, Acute Coronary Syndromes
Not applicableRecruitingJilin University26402026-03-012026-10-01
Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention
rivaroxaban and ASA, Low-molecular weight heparin, Fondaparinux - Hip Fracture Surgery, Cardiovascular Prevention
Phase 3Not yet recruitingMcMaster University1002025-12-012025-11-14
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
Aspirin 162 mg, Aspirin 81mg - Pre-Eclampsia, Pregnancy Loss
Phase 3RecruitingUniversity of Pennsylvania11502024-06-122026-09-10
Use of 81 vs 325mg of ASA in Treatment of BCVI
Acetylsalicylic Acid - Carotid Artery Injuries, Traumatic Injury
Early Phase 1UnknownLondon Health Sciences Centre402024-06-012024-04-25
Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head
Acetylsalicylic acid, Placebo - Pancreatic Cancer Resectable
Phase 2Not yet recruitingGerman Cancer Research Center1702024-04-012023-11-13
A Trial Investigating Lu AF28996 in Healthy Adult Participants
Lu AF28996, Acetylsalicylic Acid, Mefenamic Acid - Healthy Participants
Phase 1CompletedH. Lundbeck A/S222024-02-272024-06-11
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
Acetylsalicylic Acid, Placebo - Diabetic Nephropathy Type 2
Phase 2 / Phase 3Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine3552024-01-012023-10-05
Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease
Ticagrelor, Clopidogrel, Aspirin - Coronary Heart Disease
Phase 4UnknownFu Wai Hospital, Beijing, China2922023-11-152023-10-18
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
Colchicine, Prednisone, Aspirin - In-stent Restenosis
Phase 4RecruitingFu Wai Hospital, Beijing, China2522023-10-302025-08-08
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Colchicine 0.5 MG, Ticagrelor 90mg, Aspirin 75-300mg - Stroke, Stroke, Ischemic
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris28002023-05-172025-09-08
Trial to Determine Effective Aspirin Dose in COPD
Aspirin 81mg, Aspirin 162 mg, Aspirin 325mg - Pulmonary Disease, Chronic Obstructive
Phase 3RecruitingJohns Hopkins University482023-05-162026-03-16
LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
Aspirin, Tinzaparin - Preeclampsia Severe, Toxemia Of Pregnancy
Phase 4RecruitingAlexandra Hospital, Athens, Greece1002023-01-182026-01-23
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
Aspirin, Clopidogrel, Ticagrelor - Thrombosis, Arterial Occlusive Diseases
Not applicableActive not recruitingMassachusetts General Hospital1442023-01-012026-10-13
Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer
Acetylsalicylic acid - Embryo Transfer, Hypertension, Pregnancy Induced
Phase 3RecruitingCentre Hospitalier Universitaire de Liege2762022-10-252025-02-18
To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
Rivaroxaban 2.5 Mg Oral Tablet, Clopidogrel tablet, Aspirin tablet - Acute Coronary Syndrome
Phase 4UnknownSarmad Zahoor902022-10-012022-10-10
Molecular Effects of Aspirin & Metformin on Colonic Epithelium
Aspirin tablet, Metformin, Aspirin and Metformin - Colorectal Cancer, Colorectal Neoplasms
Not applicableWithdrawnUniversity of Edinburgh2022-08-012025-02-06

Showing 20 of 183. Sign in to see all of them.

Conditions studied

Stroke (15)  ·  Thrombosis (12)  ·  Ischemic Stroke (11)  ·  Colorectal Neoplasms (10)  ·  Coronary Artery Disease (9)  ·  Pre-Eclampsia (9)  ·  Atrial Fibrillation (8)  ·  Acute Coronary Syndrome (6)  ·  Cardiovascular Diseases (6)  ·  Colonic Neoplasms (6)  ·  Peripheral Arterial Disease (6)  ·  Venous Thromboembolism (6)  ·  Mucocutaneous Lymph Node Syndrome (5)  ·  Myocardial Infarction (5)  ·  Prostatic Neoplasms (5)

Sponsors

National Cancer Institute (NCI) (9)  ·  Bristol-Myers Squibb (3)  ·  Children's Hospital of Fudan University (3)  ·  Fu Wai Hospital, Beijing, China (3)  ·  Population Health Research Institute (3)  ·  Universidade Estadual Paulista Júlio de Mesquita Filho (3)  ·  Vanderbilt University (3)  ·  Xijing Hospital (3)  ·  Abbott (2)  ·  Aragon Institute of Health Sciences (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Bayer (2)  ·  Biogen (2)  ·  Boehringer Ingelheim (2)  ·  Copenhagen University Hospital, Rigshospitalet (2)

Countries

United States (51)  ·  Canada (23)  ·  China (21)  ·  Italy (19)  ·  Denmark (17)  ·  Spain (17)  ·  Switzerland (15)  ·  Germany (14)  ·  Netherlands (14)  ·  France (13)  ·  United Kingdom (13)  ·  Belgium (12)  ·  Brazil (11)  ·  South Korea (10)  ·  Australia (8)

Top investigators

Gang Zhao, M.D. (3)  ·  Francesco Violi, MD (2)  ·  Haiyan Qian, MD, PhD (2)  ·  John Mascarenhas, MD (2)  ·  Leslie Skeith, MD (2)  ·  Marc Rodger, MD (2)  ·  Mauro Santamaria, Professor (2)  ·  Roopal Thakkar, MD (2)  ·  Alan J Kivitz, MD (1)  ·  Alessandro Rambaldi, MD (1)  ·  Alfredo Perales, PhD (1)  ·  Amit Oza (1)

Results publications

PMID 35224730, PMID 36700520, PMID 37489818, PMID 40775758, PMID 1100130, PMID 11010931, PMID 11454256, PMID 15141377, PMID 15867308, PMID 16286167, PMID 16539843, PMID 16960170, PMID 16960171, PMID 17261652, PMID 17697815, PMID 17698822, PMID 18355656, PMID 18388038, PMID 18567918, PMID 18774340, PMID 19106084, PMID 19108880, PMID 19153091, PMID 19220726, PMID 19228706, PMID 19301936, PMID 19324253, PMID 19331435, PMID 19336502, PMID 19414633, PMID 19482214, PMID 19762550, PMID 19782922, PMID 20096533, PMID 20204386, PMID 20334810, PMID 20566953, PMID 2056896, PMID 20572767, PMID 20650435, PMID 20659762, PMID 20837828, PMID 20837893, PMID 20937093, PMID 20943705, PMID 20961243, PMID 21098354, PMID 21146637, PMID 21216739, PMID 21285990

NIH funding

2014 (5), 2015 (4), 2016 (3), 2017 (2), N01CN00031 (2), N01CN00034 (2), P01CA108671 (2), P30CA016672 (2), P30CA023074 (2), 2018 (1), 2023 (1), K01HL130625 (1), K23HL151758 (1), N01CN00035 (1), N01CN35000 (1)